Literature DB >> 10036219

Adverse reproductive outcomes in the transgenic Ah receptor-deficient mouse.

B D Abbott1, J E Schmid, J A Pitt, A R Buckalew, C R Wood, G A Held, J J Diliberto.   

Abstract

The aryl hydrocarbon receptor (AHR) is a transcriptional regulatory protein that binds to upstream DNA response elements of target genes. Activation of the AHR by binding of ligands such as polyhalogenated dioxins, furans, and PCBs is associated with a wide range of adverse biological outcomes, including cancer, immune deficiencies, embryo/fetotoxicity, and reproductive toxicity. Investigations of the diverse biological responses mediated by the AHR led to production of a transgenic mouse in which the gene coding for the AhR was inactivated. AHR-deficient mice were fertile and at maturity exhibited immune system impairment and hepatic fibrosis. Our laboratory received several of these homozygous knockout (-/-) mice and mated them with wild-type (+/+) C57BL/6N mice to generate large numbers of heterozygotes (+/-). The -/- males were then mated with a total of 45 heterozygous +/- females. Offspring of these matings were genotyped and mated in all genotypic combinations. Although male and female -/- adults were fertile, the -/- females had difficulty maintaining conceptuses during pregnancy, surviving pregnancy and lactation, and rearing pups to weaning. Only 46% of the 39 pregnant -/- females successfully raised pups to weaning. The -/- pups showed poor survival during lactation (average death rate per litter was 16%) and after weaning (26.5% of the 230 weaned -/- pups died within 2 weeks). Only 39% of the implantations in uteri of -/- dams resulted in offspring surviving to Postnatal Day 45. Across all litters the sex ratios and genotypic frequencies were comparable to expected values. Reproductive success was adversely affected in Ahr-null females and conceptuses. Additional study is needed to reveal the etiology of these effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10036219     DOI: 10.1006/taap.1998.8601

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  61 in total

1.  Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice.

Authors:  G P Lahvis; S L Lindell; R S Thomas; R S McCuskey; C Murphy; E Glover; M Bentz; J Southard; C A Bradfield
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

2.  Roles of aryl hydrocarbon receptor in endothelial angiogenic responses†.

Authors:  Yan Li; Chi Zhou; Wei Lei; Kai Wang; Jing Zheng
Journal:  Biol Reprod       Date:  2020-10-29       Impact factor: 4.285

3.  Expression of aryl hydrocarbon receptor in human placentas and fetal tissues.

Authors:  Yi-zhou Jiang; Kai Wang; Roy Fang; Jing Zheng
Journal:  J Histochem Cytochem       Date:  2010-03-30       Impact factor: 2.479

4.  Keratinocyte Growth Factor Regulation of Aryl Hydrocarbon Receptor Activation in Colorectal Cancer Cells.

Authors:  Jiuheng Yin; Baifa Sheng; Aimin Pu; Bin Han; Kunqiu Yang; Qimeng Wang; Lihua Sun; Hua Yang
Journal:  Dig Dis Sci       Date:  2015-10-29       Impact factor: 3.199

5.  Gene-chemical interactions in the developing mammalian nervous system: Effects on proliferation, neurogenesis and differentiation.

Authors:  Donald A Fox; Lisa Opanashuk; Aleksander Zharkovsky; Bernie Weiss
Journal:  Neurotoxicology       Date:  2010-04-08       Impact factor: 4.294

6.  Inhibition of cytochrome P4501-dependent clearance of the endogenous agonist FICZ as a mechanism for activation of the aryl hydrocarbon receptor.

Authors:  Emma Wincent; Johanna Bengtsson; Afshin Mohammadi Bardbori; Tomas Alsberg; Sandra Luecke; Ulf Rannug; Agneta Rannug
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-05       Impact factor: 11.205

7.  Ligand selectivity and gene regulation by the human aryl hydrocarbon receptor in transgenic mice.

Authors:  Colin A Flaveny; Iain A Murray; Chris R Chiaro; Gary H Perdew
Journal:  Mol Pharmacol       Date:  2009-03-19       Impact factor: 4.436

8.  Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators.

Authors:  Carolyn D DuSell; Erik R Nelson; Bryan M Wittmann; Jackie A Fretz; Dmitri Kazmin; Russell S Thomas; J Wesley Pike; Donald P McDonnell
Journal:  Mol Endocrinol       Date:  2009-11-09

Review 9.  Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target.

Authors:  Stephen Safe; Syng-Ook Lee; Un-Ho Jin
Journal:  Toxicol Sci       Date:  2013-06-14       Impact factor: 4.849

10.  Dietary fat alters body composition, mammary development, and cytochrome p450 induction after maternal TCDD exposure in DBA/2J mice with low-responsive aryl hydrocarbon receptors.

Authors:  Michele La Merrill; Bittu S Kuruvilla; Daniel Pomp; Linda S Birnbaum; David W Threadgill
Journal:  Environ Health Perspect       Date:  2009-05-18       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.